***********************************
Brakke Consulting’s
Animal Health News & Notes for June 15, 2012
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke news
Industry Roundtable
other news
Hospira
Huvepharma
Merck
Novartis
***********************************
BRAKKE CONSULTING, INC.
ANIMAL HEALTH INDUSTRY ROUNDTABLE
JUNE 20, 2012
Brakke Consulting and Stinson Morrison Hecker LLP will hold the first Animal Health Breakfast Roundtable in Kansas City on June 20. The Roundtable will feature Ron Brakke and Susan Warren, both from Brakke Consulting, who will highlight pertinent news and developments over the last six months that could affect the industry.
The program will begin at 8 a.m. at 1201 Walnut Street, Suite 2900. There is no charge, but you must register to attend. The deadline for online registration is June 13. To register online, go to http://www.stinson.com/animalhealthroundtablejune20/.
www.BrakkeConsulting.com
************************************
COMPANY NEWS RELEASES
> Merck Animal Health announced the US launch of Activyl and Activyl Tick Plus.Activyl is a topical, once-a-month ectoparasiticide containing indoxacarb; Activyl Tick Plus also contains permethrin. Activyl is the first flea control product to utilize metabolic activation, or bioactivation of the active ingredient, to kill fleas. Activyl and Activyl Tick Plus will be available only through licensed veterinarians. (company website)
> Novartis Animal Health US, Inc. announced the launch of Onsior (robenacoxib), the first three-day NSAID (non-steroidal anti-inflammatory drug) for relief of pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration in cats. Onsior tablets are administered once daily for up to three days. (company press release)
> The FDA announced that it has approved Hospira’s ANADA for Ceftiofur for Injection for use in cattle, swine, sheep, goats, horses, dogs, and poultry. Ceftiofur for injection is a generic equivalent for Pfizer’s Naxcel. (FDA)
> The FDA announced that it has approved Huvepharma’s ANADA for Tylovet 100 (tylosin phosphate) medicated feed additive for use in beef cattle, chickens and swine. Tylovet 100 is a generic equivalent of Elanco’s Tylan 100. (FDA)
***********************************
ANIMAL HEALTH NEWS
> ITALY – NEWCASTLE DISEASE The Italian veterinary authorities have alerted the World Organization for Animal Health (OIE) to multiple outbreaks of Newcastle disease. Both alerts involved backyard pigeon flocks. The source of both these outbreaks remains undiscovered. (Animal Pharm)
> US – CHRONIC WASTING DISEASE The USDA’s Animal and Plant Health Inspection Service (APHIS) announced an interim final rule to establish a national chronic wasting disease (CWD) herd certification program and minimum requirements for interstate movement of deer, elk and moose, or cervids, in the US. Participation in the program will be voluntary. The interim final rule amends the Agency’s 2006 final rule which was never put into effect. (KHOU.com)
> US – ANIMAL ID A coalition of agriculture and consumer organizations sent a joint letter to the Congressional Office of Management and Budget (OMB), challenging the USDA’s decision to push ahead with an national Animal ID program and claiming that the USDA’s estimates grossly underestimated the cost per animal and the number of animals affected. The USDA had estimated the fiscal impacts at under $100 million, claiming that the rule is not “economically significant” and placing it on the fast-track to be finalized after review by the OMB. (WesternFarmPress.com)
************************************
KC ANIMAL HEALTH INVESTMENT FORUM
AUGUST 28, 2012
LAST WEEK FOR PRESENTERS TO APPLY
The KC Animal Health Corridor is now accepting applications for the fourth annual KC Animal
Health Investment Forum in Kansas City, Missouri.
The forum will showcase animal health and nutrition companies from throughout the world.
The selection committee will consider companies that meet the following criteria:
• Seeking $500,000 to $20 million in funding
• Revenue projections of $20 million within five to seven years
Applications must be submitted by June 22, 2012. All companies will be contacted by July 27 regarding their acceptance. Apply online at www.kcanimalhealthforum.com . For questions, email Kimberly Young at young@thinkkc.com or call 816.374.5627.
************************************
BRAKKE CONSULTING VIEWPOINT
We’re only a couple of weeks from closing out the first 6 months of 2012. It’s been an interesting 6 months for the industry. We entered the year with some concerns over what might happen to the economy based on $4 plus per gallon gasoline, escalating food prices and drought conditions in many parts of the food production area. This week gasoline prices dropped back to low $3 range with some economists suggesting the high $2 range before long. While food prices have increased some, consumers have adjusted nicely and many parts of the US are receiving significant rain. Even with all the political posturing and spinning the unemployment numbers continue to hover around 8%.
In our opinion these changes versus early expectations is good news for the animal health industry at all levels. It appears to us that 2012 is going to end up looking a lot like 2011 with some nice revenue increases and in some cases even unit volume increases. We hope that is true for your firm.
Have a great weekend!!
Ron Brakke
************************************
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX 75234 USA
English (United States) 
Portuguese